Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia

Clinical Immunology

Volumn 125, Issue 3, 2007, Pages 328-336

  Dessing, Mark C ^a,b   van der Sluijs, Koenraad F ^a   Florquin, Sandrine ^a   van der Poll, Tom ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Influenza; Mice; Monocyte chemoattractant protein 1; Pneumonia

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GRANULOCYTE; IMMUNE RESPONSE; INFLUENZA; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VIRUS LOAD; WEIGHT GAIN; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; CHEMOKINE CCL2; CHEMOKINE CXCL2; FLOW CYTOMETRY; INFLUENZA A VIRUS; INTERFERON TYPE II; INTERLEUKIN-6; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA, VIRAL; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD;

EID: 36148961607     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.08.001     Document Type: Article

References (55)

1. Murphy BRaW R.G. Orthomyxovirusses. In: Filds B.N.K.D.M., and Howley P.M. (Eds). Fields Virology. 3rd ed. (1996), Lippincott-Raven, Philadelphia 1407
2. Treanor J.J. Orthomyxoviridae: influenza virus. In: Mandell GLDoDRB J.E., and Dolin R. (Eds). Principles and Practice of Infectious Diseases. 5th ed. (2000), Churchill Livingston, New York 1834-1835
3. Ronni T., Sareneva T., Pirhonen J., and Julkunen I. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J. Immunol. 154 (1995) 2764-2774
4. Julkunen I., Sareneva T., Pirhonen J., Ronni T., Melen K., and Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev. 12 (2001) 171-180
5. Dawson T.C., Beck M.A., Kuziel W.A., Henderson F., and Maeda N. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am. J. Pathol. 156 (2000) 1951-1959
6. Li F., Wang Q.J., Zhu BL., and Wang M. Antiviral effects of rhIFN-alpha 1 against seven influenza viruses. Zhongguo Yaoli Xuebao 20 (1999) 709-714
7. Sakai S., Kawamata H., Mantani N., et al. Therapeutic effect of anti-macrophage inflammatory protein 2 antibody on influenza virus-induced pneumonia in mice. J. Virol. 74 (2000) 2472-2476
8. Sakai S., Ochiai H., Mantani N., Kogure T., Shibahara N., and Terasawa K. Administration of isoferulic acid improved the survival rate of lethal influenza virus pneumonia in mice. Mediat. Inflamm. 10 (2001) 93-96
9. Peper R.L., and Van Campen H. Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb. Pathog. 19 (1995) 175-183
10. Kostense S., Sun W.H., Cottey R., et al. Interleukin 12 administration enhances Th1 activity but delays recovery from influenza A virus infection in mice. Antivir. Res. 38 (1998) 117-130
11. Monteiro J.M., Harvey C., and Trinchieri G. Role of interleukin-12 in primary influenza virus infection. J. Virol. 72 (1998) 4825-4831
12. Tsurita M., Kurokawa M., Imakita M., Fukuda Y., Watanabe Y., and Shiraki K. Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection. J. Pharmacol. Exp. Ther. 298 (2001) 362-368
13. van der Sluijs K.F., van Elden L.J., Xiao Y., et al. IL-12 deficiency transiently improves viral clearance during the late phase of respiratory tract infection with influenza A virus in mice. Antivir. Res. 70 2 (2006) 75-84
14. Liu B., Mori I., Hossain M.J., Dong L., Takeda K., and Kimura Y. Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J. Gen. Virol. 85 (2004) 423-428
15. Van Der Sluijs K.F., Van Elden L.J., Arens R., et al. Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus. Immunology 114 (2005) 112-120
16. Graham M.B., Dalton D.K., Giltinan D., Braciale V.L., Stewart T.A., and Braciale T.J. Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J. Exp. Med. 178 (1993) 1725-1732
17. Price G.E., Gaszewska-Mastarlarz A., and Moskophidis D. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice. J. Virol. 74 (2000) 3996-4003
18. Daly C., and Rollins B.J. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 10 (2003) 247-257
19. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18 (2000) 217-242
20. Coelho A.L., Hogaboam C.M., and Kunkel S.L. Chemokines provide the sustained inflammatory bridge between innate and acquired immunity. Cytokine Growth Factor Rev. 16 (2005) 553-560
21. Carr M.W., Roth S.J., Luther E., Rose S.S., and Springer T.A. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 3652-3656
22. Matsukawa A., Hogaboam C.M., Lukacs N.W., Lincoln P.M., Strieter R.M., and Kunkel S.L. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J. Immunol. 163 (1999) 6148-6154
23. Speyer C.L., Gao H., Rancilio N.J., et al. Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am. J. Pathol. 165 (2004) 2187-2196
24. Kurihara T., Warr G., Loy J., and Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186 (1997) 1757-1762
25. Boring L., Gosling J., Chensue S.W., et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100 (1997) 2552-2561
26. Huffnagle G.B., Strieter R.M., Standiford T.J., et al. The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 155 (1995) 4790-4797
27. Doherty P.C., Topham D.J., Tripp R.A., Cardin R.D., Brooks J.W., and Stevenson P.G. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159 (1997) 105-117
28. Franci C., Wong L.M., Van Damme J., Proost P., and Charo I.F. Monocyte chemoattractant protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the human monocyte chemoattractant protein-1 receptor. J. Immunol. 154 (1995) 6511-6517
29. Combadiere C., Ahuja S.K., Van Damme J., Tiffany H.L., Gao J.L., and Murphy P.M. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J. Biol. Chem. 270 (1995) 29671-29675
30. Garcia-Zepeda E.A., Combadiere C., Rothenberg M.E., et al. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J. Immunol. 157 (1996) 5613-5626
31. Stellato C., Collins P., Ponath P.D., et al. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J. Clin. Invest. 99 (1997) 926-936
32. Sarafi M.N., Garcia-Zepeda E.A., MacLean J.A., Charo I.F., and Luster A.D. Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J. Exp. Med. 185 (1997) 99-109
33. van Elden L.J., Nijhuis M., Schipper P., Schuurman R., and van Loon A.M. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J. Clin. Microbiol. 39 (2001) 196-200
34. Knapp S., Leemans J.C., Florquin S., et al. Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am. J. Respir. Crit. Care Med. 167 (2003) 171-179
35. Traynor T.R., Kuziel W.A., Toews G.B., and Huffnagle G.B. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J. Immunol. 164 (2000) 2021-2027
36. Peters W., Scott H.M., Chambers H.F., Flynn J.L., Charo I.F., and Ernst J.D. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 7958-7963
37. Sato N., Kuziel W.A., Melby P.C., et al. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice. J. Immunol. 163 (1999) 5519-5525
38. Lu B., Rutledge B.J., Gu L., et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187 (1998) 601-608
39. Cook D.N., Beck M.A., Coffman T.M., et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269 (1995) 1583-1585
40. Allan W., Tabi Z., Cleary A., and Doherty P.C. Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J. Immunol. 144 (1990) 3980-3986
41. Eichelberger M., Allan W., Zijlstra M., Jaenisch R., and Doherty P.C. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J. Exp. Med. 174 (1991) 875-880
42. Scherle P.A., Palladino G., and Gerhard W. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J. Immunol. 148 (1992) 212-217
43. Luther S.A., and Cyster J.G. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2 (2001) 102-107
44. Wijburg O.L., DiNatale S., Vadolas J., van Rooijen N., and Strugnell R.A. Alveolar macrophages regulate the induction of primary cytotoxic T-lymphocyte responses during influenza virus infection. J. Virol. 71 (1997) 9450-9457
45. Tumpey T.M., Garcia-Sastre A., Taubenberger J.K., et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 79 (2005) 14933-14944
46. Tamura S., and Kurata T. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn. J. Infect. Dis. 57 (2004) 236-247
47. Mazanec M.B., Coudret C.L., and Fletcher D.R. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J. Virol. 69 (1995) 1339-1343
48. Renegar K.B., and Small Jr. P.A. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 146 (1991) 1972-1978
49. Renegar K.B., and Small Jr. P.A. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J. Virol. 65 (1991) 2146-2148
50. Asahi Y., Yoshikawa T., Watanabe I., et al. Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines. J. Immunol. 168 (2002) 2930-2938
51. Matsukura S., Kokubu F., Noda H., Tokunaga H., and Adachi M. Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. J. Allergy Clin. Immunol. 98 (1996) 1080-1087
52. Adachi M., Matsukura S., Tokunaga H., and Kokubu F. Expression of cytokines on human bronchial epithelial cells induced by influenza virus A. Int. Arch. Allergy Immunol. 113 (1997) 307-311
53. Huang Q., Liu D., Majewski P., et al. The plasticity of dendritic cell responses to pathogens and their components. Science 294 (2001) 870-875
54. Jego G., Palucka A.K., Blanck J.P., Chalouni C., Pascual V., and Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19 (2003) 225-234
55. Kozak W., Poli V., Soszynski D., Conn C.A., Leon L.R., and Kluger M.J. Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am. J. Physiol. 272 (1997) R621-R630